Company Info
| Phone: | (781) 357-2333 |
| Year Established: | 2003 |
| Ticker: | PULM |
| Exchange: | NASDAQ |
Contacts
| Primary: | Ted Raad CEO |
| Other: | Margaret Wasilewski, MD CMO Peter Ludlam Interim CFO |
Company Description
Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSEļ¾ technology.
